An approach to the development of novel antihypertensive drugs: potential role of sodium pump inhibitors.
Second Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Japan.
A
A
Goto
K
K
Yamada
D000818:Animals; D000959:Antihypertensive Agents / Q000737:chemistry / Q000627:therapeutic use*; D015195:Drug Design; D004791:Enzyme Inhibitors / Q000302:isolation & purification / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000209:etiology; D010042:Ouabain / Q000031:analogs & derivatives*; D051381:Rats; D012964:Sodium / Q000378:metabolism; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors*
D000959:Antihypertensive Agents; D004791:Enzyme Inhibitors; D010042:Ouabain; D012964:Sodium; D000254:Sodium-Potassium-Exchanging ATPase